Inside Indias cancer capital as it rethinks cancer care Globally, the burden of cancer is growing, increasing the demand for effective cancer care India sits at the center of this shift, a challenge felt most acutely in regions like Meghalaya
Possibilities and Limits of Cancer Care - The World Economic Forum Despite major advances in diagnostics and treatment, cancer remains a leading cause of death worldwide Yet a new wave of innovation is reshaping what may be possible, from personalized cancer vaccines designed to train a patient’s immune system to AI-enabled tools that can detect or predict cancers earlier and at scale Join this session to learn what the latest research and emerging
Womens cancer is getting worse in Asia Pacific Cancer is a huge problem in Asia Pacific — and it is growing But the fight isn't over Governments can act to bring down the rates of cancer in women
AI can unlock cancer’s complexities — if we build the data . . . We can measure cancer (and its treatment) as a living, dynamic system On the other side, AI architectures have matured to ingest exactly this type of multimodal data — genomic, spatial and longitudinal — at scales humans simply cannot process For the first time, the measurement tools and the computational tools are aligned
Forums global womens health alliance expands to Zambia On 17 November, the world marks the Cervical Cancer Elimination Day of Action As part of its ongoing work to drive progress against women's cancers, the World Economic Forum's Global Alliance for Women's Health launched its Breast and Cervical Cancer Coalition in Zambia At a workshop in Lusaka, the Coalition addressed cancer prevention, screening, and treatment gaps in line with Zambia’s
Why rare diseases are a proving ground for medical innovation Rare diseases are a proving ground for medical innovation, shaping breakthroughs in genomics, gene therapy, AI and precision medicine Stronger, interoperable data foundations can accelerate diagnosis, unlock new treatments, reduce costs and improve outcomes By investing in better data, smarter regulation and cross-border collaboration, rare disease innovation can benefit entire health systems